United Kingdom exceeds 10 million vaccinated | COVAX will distribute 337 million doses in 145 countries

In the United Kingdom, 10 million people have already received the first dose of the coronavirus vaccine and almost half a million have received the second, according to official figures.

But Prime Minister Boris Johnson does not lower his guard and assures that the country is not out of the woods yet. The count of daily deaths remains above a thousand.

“Although we have some encouraging data today, such as the number of COVID patients in hospitals that is starting to decline for the first time since the start of the third wave, the level of infection is still alarmingly high, and I regret to say that we have lost others. 1,322 lives in the last 24 hours, “Johnson announced.

Meanwhile, a preliminary study indicates that the AstraZeneca vaccine can reduce transmission of the virus by 76% in its first dose. The effectiveness increases to 82% after the second dose, according to the analysis of the University of Oxford, a contributor to the vaccine.

In an effort to curb the variants of COVID, the companies GlaxoSmithKline and CureVac have agreed to develop a new vaccine that can address the mutations. An ambitious collaboration valued at 150 million euros. This vaccine is currently in phase 2 and 3 of the clinical trial.

The emergence of new strains of the COVID-19 virus may reduce the effectiveness of the first generation of vaccines, so it is necessary to accelerate efforts to develop vaccines against mutations to stay one step ahead of the pandemic, according to both companies. .

The COVAX program, created to promote equitable access to vaccines that are developed against covid-19, announced this Wednesday that it plans to distribute a total of 337 million doses to low and middle-income countries in a first phase that will begin between the end this month and early March. Of which UNICEF will distribute 100 million doses.

“UNICEF, together with our partners and including the Pan American Health Organization, will have access to some 1.1 billion doses for a hundred countries. The price of the vaccine will be approximately three dollars for low- and middle-income countries. “said the executive director of the entity, Henrietta Fore.

The total announced doses cover 3.3% of the population of the 145 countries that will receive the doses.

Different vaccines from different pharmaceutical companies are currently part of the global fight against the virus. Many insist on drawing up a comprehensive plan of action.